Society of Toxicology 2021 Virtual Conference


Come and visit our Booth # 1411.

ApconiX are giving a number of poster presentations, talks and an Exhibitor Hosted Session.  Read on to find out more…

Professor Ruth Roberts introduces ApconiX to SOT 2021 (This video has closed captions – if you would like to see these just click on “CC” on the control panel):

Poster Presentations:



Professor Ruth Roberts

Abstract Number/Poster Board number: 3180/ P163
Abstract Title: Species Specific Urothelial Toxicity with an Anti-HIV Non-catalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes
Presenting Author: Ruth Roberts
Session Title: Safety Assessment: Pharmaceutical—Drug Development
Session Time: 3/25/2021 1:00:00 PM to 3/25/2021 2:45:00 PM

Ruth as a co-author

Abstract Number/Poster Board number: 2518/ P256
Abstract Title: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation
Presenting Author: Ting Li
Session Title: Bioinformatics
Session Time: 3/22/2021 1:00:00 PM to 3/22/2021 2:45:00 PM

Abstract Number/Poster Board number: 2482/ P220
Abstract Title: CSF Proteome as Fluidic Biomarkers of Neurotoxicity
Presenting Author: Syed Imam
Session Title: Neurotoxicity: General
Session Time: 3/22/2021 11:15:00 AM to 3/22/2021 1:00:00 PM

Phumzile Sikakana

Abstract Number/Poster Board number: 2208/ P201
Abstract Title: A Decade of Toxicological Trends: What the Papers Say
Presenting Author: Phumzile Sikakana
Session Title: Systems Biology
Session Time: 3/17/2021 1:00:00 PM to 3/17/2021 2:45:00 PM


Dr Jane Barber

Abstract Number: 2354
Abstract Title: Target Safety Assessments: Evaluation of the Toxicological Risk of Targeting Prolyl-tRNA Synthetase (PRS) in the Treatment of Malaria
Presenting Author: Jane Barber
Session Title: Pharmaceutical Safety Assessment: Spotlight
Session Time: 3/22/2021 11:15:00 AM to 3/22/2021 2:00:00 PM
Presentation Time: 3/22/2021 11:30:00 AM to 3/22/2021 11:45:00 AM

Exhibitor Hosted Session:

Hosted by: ApconiX Ltd
Session Title: An Integrated Approach to Cardiac Safety and CiPA
Session Description:
We describe the importance and benefits of an integrated approach to in vitro cardiac safety testing and the CiPA paradigm. We show how the combination of high-throughput and rapid automated ion channel testing, and more complex models of cardiac safety, inform decision making during drug discovery. 
Presenters: Dr Michael Morton (Director and Co-founder of ApconiX) and Richard Printemps (Physiostim)
Session Date: March 16, 2021
Session Time: 09:00 AM-10:00 AM